Janux Therapeutics (JANX) Earnings Date, Estimates & Call Transcripts → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free JANX Stock Alerts $50.41 +2.81 (+5.90%) (As of 05/30/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 7) -$0.30 Beat By $0.05 Consensus EPS (May. 7) -$0.35 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueJANX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JANX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” Janux Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.41)($0.29)($0.36)Q2 20243($0.38)($0.21)($0.30)Q3 20243($0.49)($0.23)($0.36)Q4 20243($0.41)($0.23)($0.34)FY 202412($1.69)($0.96)($1.36)Q1 20253($0.47)($0.24)($0.37)Q2 20253($0.52)($0.25)($0.40)Q3 20253($0.58)($0.25)($0.42)Q4 20253($0.59)($0.26)($0.44)FY 202512($2.16)($1.00)($1.63)JANX Earnings Date and InformationJanux Therapeutics last released its earnings data on May 7th, 2024. The reported ($0.30) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.35) by $0.05. The company had revenue of $1.25 million for the quarter, compared to analysts' expectations of $0.98 million. Janux Therapeutics has generated ($1.22) earnings per share over the last year (($1.22) diluted earnings per share). Earnings for Janux Therapeutics are expected to decrease in the coming year, from ($1.34) to ($1.63) per share. Janux Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Janux Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/7/2024Q1 2024($0.35)($0.30)+$0.05($0.30)$0.98 million$1.25 million3/8/2024Q4 2023($0.37)($0.25)+$0.12($0.25)$0.98 million$2.46 million11/7/2023Q3 2023($0.46)($0.25)+$0.21($0.25)$1.22 million$2.52 million8/8/2023Q2 2023($0.52)($0.42)+$0.10($0.42)$1.25 million$1.06 million5/9/2023Q1 2023($0.49)($0.42)+$0.07($0.42)$1.69 million$2.05 million3/10/2023Q4 2022($0.45)($0.39)+$0.06($0.39)$1.69 million$2.85 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”11/10/2022Q3 2022($0.51)($0.40)+$0.11($0.40)-$1.81 million8/9/2022Q2 2022($0.37)($0.41)($0.04)($0.41)-$2.37 million5/10/2022Q1 2022($0.37)($0.32)+$0.05($0.32)-$1.59 million3/18/2022Q4 2021($0.30)($0.33)($0.03)($0.33)-$1.62 million11/9/2021Q3 2021($0.18)($0.26)($0.08)($0.26)-$1.16 million8/10/2021Q2 2021($0.14)($0.62)($0.48)($0.62)-$0.48 million Janux Therapeutics Earnings - Frequently Asked Questions When is Janux Therapeutics's earnings date? Janux Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on JANX's earnings history. Did Janux Therapeutics beat their earnings estimates last quarter? In the previous quarter, Janux Therapeutics (NASDAQ:JANX) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.05. Learn more on analysts' earnings estimate vs. JANX's actual earnings. How much revenue does Janux Therapeutics generate each year? Janux Therapeutics (NASDAQ:JANX) has a recorded annual revenue of $8.08 million. How much profit does Janux Therapeutics generate each year? Janux Therapeutics (NASDAQ:JANX) has a recorded net income of -$58.29 million. JANX has generated -$1.22 earnings per share over the last four quarters. What is Janux Therapeutics's EPS forecast for next year? Janux Therapeutics's earnings are expected to decrease from ($1.34) per share to ($1.63) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MLTX Earnings Date ACAD Earnings Date TGTX Earnings Date MRUS Earnings Date BHC Earnings Date ARVN Earnings Date INDV Earnings Date RYTM Earnings Date MRVI Earnings Date DCPH Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Abercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the Dip This page (NASDAQ:JANX) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.